Lynx1 Capital Management’s TScan Therapeutics TCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.4M | Buy |
7,857,347
+2,500,000
| +47% | +$3.63M | 3.29% | 7 |
|
|
2025
Q1 | $7.39M | Hold |
5,357,347
| – | – | 2.65% | 8 |
|
|
2024
Q4 | $16.3M | Buy |
5,357,347
+132,747
| +3% | +$404K | 6.11% | 6 |
|
|
2024
Q3 | $26M | Hold |
5,224,600
| – | – | 9.22% | 5 |
|
|
2024
Q2 | $30.6M | Hold |
5,224,600
| – | – | 11.03% | 5 |
|
|
2024
Q1 | $41.5M | Hold |
5,224,600
| – | – | 10.68% | 4 |
|
|
2023
Q4 | $30.5M | Hold |
5,224,600
| – | – | 11.98% | 4 |
|
|
2023
Q3 | $13.4M | Hold |
5,224,600
| – | – | 8.85% | 5 |
|
|
2023
Q2 | $13.1M | Buy |
+5,224,600
| New | +$13.1M | 8.56% | 5 |
|